Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma?a comparison between L-TAE with Farmorubicin and L-TAE with Adriamycin: preliminary results (second cooperative study)
Cancer Chemotherapy and Pharmacology1994Vol. 33(S1), pp. S97–S102
Citations Over Time
Saburo Kawai, Masayoshi Tani, Jun Okamura, Makoto Ogawa, Yasuo Ohashi, Morito Monden, Shigeki Hayashi, J. Inoue, Yoshifumi Kawarada, Mitsuo Kusano, Yasuhiko Kubo, C Kuroda, Yu Sakata, Y Shimamura, Kenji Jinno, Akira Takahashi, Kenichi Takayasu, Kazuo Tamura, Naofumi Nagasue, Yoshimi Nakanishi, M Makino, Manabu Masuzawa, Yasuhiro Yumoto, Takesada Mori, Toshitsugu Oda, The Cooperative Study Group for Liver Cancer Treatment of Japan
Related Papers
- → Distribution of Lipiodol and Evidence for Tumor Necrosis in Hepatocellular Carcinoma(1992)11 cited
- [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].(1987)
- → Tissue Tolerance to Pelvic Intraarterial Chemoembolization with Cisplatin-Lipiodol Suspension(1993)2 cited
- Selective accumulation , persistent deposition and gradual disappear-ance of lipiodol in hepatocellular carcinoma following hepatic arterial chemoembo1ization(1994)
- [Tissue tolerance to pelvic intraarterial chemoembolization].(1993)